Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDAMA Allows Novel Genetic Tests To Be Regulated As 510(k)s - CDRH

This article was originally published in The Gray Sheet

Executive Summary

FDA will likely regulate most genetic tests through the premarket notification process and its related controls - including manufacturing, labeling, adverse event reporting and postmarket study controls, according to Center for Devices and Radiological Health officials.

You may also be interested in...



Nephrology Test Opportunity Drives Behrman Buy-Out Of Athena Diagnostics

Behrman Capital's agreement to purchase the Athena Diagnostics unit from Elan illustrates the private equity firm's commitment to commercializing Athena's esoteric nephrology testing capabilities

Nephrology Test Opportunity Drives Behrman Buy-Out Of Athena Diagnostics

Behrman Capital's agreement to purchase the Athena Diagnostics unit from Elan illustrates the private equity firm's commitment to commercializing Athena's esoteric nephrology testing capabilities

HHS Begs Novel Approach To Genetic Tests Pending FDA Authority Verdict

The HHS Secretary's Advisory Committee on Genetic Testing is planning on a final legal review decision from FDA on oversight and premarket review of genetic tests in time for its August meeting

Related Content

UsernamePublicRestriction

Register

MT014523

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel